Loading company
Just reported
From electroCore's results release of November 4, 2026; its quarterly report has since been filed.
Actual
$9.7M
+12% y/y
+2.5% q/q
Guided
—
No guide given
Actual
-$0.13
Guided
—
No guide given
Actual
-$1.6M
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes electroCore is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
MDTMedtronic plc$131.6BA+
SYKStryker Corp.$117.9BA+
EWEdwards Lifesciences Corporation$61.6BA+
GEHCGE Healthcare Technologies Inc.$37.5BA
GKOSGlaukos Corp$14.5BARose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher CorporationOct 21, 2026CBGraded C, now B
MCKMckesson CorporationNov 4, 2026BAGraded B, now A
CVSCVS Health CorpNov 4, 2026BAGraded B, now AEWEdwards Lifesciences CorporationNov 4, 2026BAGraded B, now AGEHCGE Healthcare Technologies Inc.Oct 28, 2026CAGraded C, now ABuilt from electroCore, Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
Company outlook: revenue of $39M to $42M for Fiscal year 2026 — up 26.4% on a year earlier
Grade D
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 31 quarters of electroCore, Inc.’s grade history. The other 29 go back to May 2019.
